Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ANAPROX 275 MG

NAPROXEN SODIUM : 275 MG · DIN 02162725 · SEARCHLIGHT PHARMA INC

Health Canada status: MARKETED

What is ANAPROX?

ANAPROX 275 MG contains NAPROXEN SODIUM : 275 MG. It is listed in the Health Canada Drug Product Database under DIN 02162725, held by SEARCHLIGHT PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 26-Jun-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is ANAPROX used for?

The relief of mild to moderately severe pain, accompanied by inflammation in conditions such as musculoskeletal trauma and post-dental extraction. The relief of pain associated with post-partum cramping and dysmenorrhea.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02162725
Brand nameANAPROX
Generic / active ingredientNAPROXEN SODIUM : 275 MG
ManufacturerSEARCHLIGHT PHARMA INC
Strength275 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeM01AE02 NAPROXEN
AHFS class28:08.04.92
BiosimilarNo
Health Canada statusMARKETED
Status date26-Jun-2025
Original market date1995-12-31 00:00:00

How is it stored and handled?

null

How is it supplied?

ANAPROX 275 mg: Available in bottles of 100, 500 and 1000 tablets. ANAPROX DS 550 mg: Available in bottles of 100, 500 and 1000 tablets.

What can be used instead?

Other Canadian products sharing ATC code M01AE02 NAPROXEN. 31 of 125 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
ALEVE BACK AND BODY PAIN220 MGCAPSULEBAYER INCMARKETEDDIN 02436337
ALEVE CAPLETS220 MGTABLETBAYER INCMARKETEDDIN 02301733
ALEVE LIQUID GELS220 MGCAPSULEBAYER INCMARKETEDDIN 02361795
ALEVE NIGHTTIME220 MGTABLETBAYER INCMARKETEDDIN 02444593
ANAPROX DS550 MGTABLETSEARCHLIGHT PHARMA INCMARKETEDDIN 02162717
APO-NAPRO-NA275 MGTABLETAPOTEX INCMARKETEDDIN 00784354
APO-NAPRO-NA DS550 MGTABLETAPOTEX INCMARKETEDDIN 01940309
APO-NAPROXEN250 MGTABLETAPOTEX INCMARKETEDDIN 00522651
APO-NAPROXEN375 MGTABLETAPOTEX INCMARKETEDDIN 00600806
APO-NAPROXEN500 MGTABLETAPOTEX INCMARKETEDDIN 00592277

Who else supplies NAPROXEN worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. NAPROXEN appears in 1493 registered pack listings across 13 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for ANAPROX

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for ANAPROX

Health Canada Drug Product Database (DPD), DIN 02162725. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.